Biophysical Corporation manages and markets biomarker-based health assessments direct to consumers and corporations, and through physicians and partnerships with nationally-acclaimed wellness centers. Offering a superior service experience of personalized materials and private consultations with medical professionals, Biophysical provides the most comprehensive blood-based assessments of an individual's health.
Biophysical is led by an expert team of researchers and doctors who've spent years developing advanced testing technologies for hospitals, universities and pharmaceutical companies around the world. Today, a dedicated executive team and a board of internationally-renowned physicians and scientists from leading medical institutions support the continued advancement of the company's flagship health assessment, Biophysical250, and the development of new biomarker-based health assessment services.
Our Medical Team
Founded by leading researchers and doctors
Dr. Rodgers graduated summa cum laude from Harvard University and the University of Texas Southwestern Medical School in Dallas. He completed his residency training at the University of Texas Medical School and cardiology fellowship at the Baylor College of Medicine in Houston. Dr. Rodgers is board-certified in both Internal Medicine and the sub-specialty of Cardiovascular Disease and entered private practice in Austin, Texas, in 1989. Prior to joining Biophysical as president and chief medical officer, he was medical director for Heart Hospital of Austin, one of the nation’s premier facilities for cardiovascular care. He was also president of the Austin Heart cardiology group from 1999 to 2004, where he continues to practice clinical cardiology. A noted authority in providing cardiovascular care and information to residents of Central Texas, he has served on numerous regional and national committees on cardiovascular disease throughout his career. He was elected chairman for the American College of Cardiology Board of Governors in 2007 and also serves as president of the Championship Hearts Foundation and president of the Texas Chapter of the American College of Cardiology. The principal investigator for numerous research projects, Dr. Rodgers has published more than 40 clinical articles in medical journals and is a member of the American Heart Hospital Journal editorial board. He has a special interest in the early detection and treatment of atherosclerosis and is the founding member of the Society of Atherosclerosis Imaging.
Dr. Alexander graduated from Rice University and the University of Texas Southwestern Medical School. She completed her internship and residency in internal medicine at Parkland Memorial Hospital and Dallas VA Medical Center. During her residency, she was an instructor in clinical medicine for the Department of Internal Medicine at UT Southwestern Medical Center in Dallas. She was later assistant professor of Internal Medicine for the Division of General Internal Medicine at UT Southwestern Medical Center and assistant professor of Internal Medicine for the Division of Community Internal Medicine at the Texas A&M University Health Science Center at Scott & White in Temple, Texas, where she was also medical student preceptor and instructor for flexible sigmoidoscopy instruction. Dr. Alexander is a Board-Certified Diplomate of The American Board of Internal Medicine. She moved to private practice in 1999 in Austin, Texas and in 2003 entered solo practice there. She is a member of the American Medical Association, Texas Medical Association, American College of Physicians and the Travis County Medical Society.
Dr. Blevins graduated from the University of Texas at Austin and Baylor College of Medicine in Houston, Texas, where he also completed his internal medicine and endocrinology training. He is Board Certified in Internal Medicine, Endocrinology, and Metabolism and certified by The International Society for Clinical Densitometry (ISCD) in Clinical Densitometry (Osteoporosis Testing). In 1986, Dr. Blevins joined the Austin Diagnostic Clinic in Austin where he was a practicing physician until 2001 when he founded Texas Diabetes and Endocrinology, a practice devoted to bringing the latest in diabetes advances, thyroid care, cholesterol management and osteoporosis diagnostics and treatment to Central Texas. A recipient of the prestigious American Diabetes Association Provider Recognition Award, Dr. Blevins also serves as Chief of Endocrinology at Seton Hospital and St. David's Medical Center in Austin. To provide innovative treatments to his patients, he participants in clinical research studies on endocrine diseases. He is a nationally-recognized speaker and educator for a number of topics in the areas of diabetes, osteoporosis, lipid management and thyroid disease. Dr. Blevins is a Fellow of the American Association of Clinical Endocrinology and is a member of the American Diabetes Association, the International Society of Clinical Densitometry, the National Lipid Education Council and the National Diabetes Education Initiative.
Our Medical Advisory Board
Internationally renowned medical experts in biomarker research
Dr. Thomas Blevins attended the University of Texas at Austin as an undergraduate, majoring in Plan II. He attended medical school at the Baylor College of Medicine in Houston and completed his internal medicine and endocrinology training there as well. He founded Texas Diabetes and Endocrinology, a practice devoted to bringing the latest in diabetes advances, thyroid care and osteoporosis diagnostics and treatment. Dr. Blevins is Board Certified in Internal Medicine, Endocrinology, and Metabolism and serves as Chief of Endocrinology at Seton Hospital and St. David's Medical Center. Dr. Blevins is also a Fellow of the American Association of Clinical Endocrinology, Member of the American Diabetes Association and Member of the International and Society of Clinical Densitometry.
Dr. Farias-Eisner is a foremost authority on gynecologic oncology and biomarker discovery and research. After graduating from the Royal College of Surgeons in Dublin, Ireland, he performed her residency in emergency medicine/critical care at the University of Illinois/University of Chicago, where he served as chief resident and was a member of the junior faculty at the University of Illinois. Dr. Farias-Eisner completed a second residency program in obstetrics and gynecology at the UCLA School of Medicine, where he was also chief resident, followed by a fellowship in gynecologic oncology. He received a Ph.D. in molecular biology from Molecular Biology Institute, David Geffen School of Medicine at UCLA under the Physician-Scientist Star Program. An acclaimed professor in the Department of Obstetrics and Gynecology at the UCLA School of Medicine since 1993, Dr. Farias-Eisner is a frequent lecturer at medical meetings and an investigator and recipient of numerous grants for women’s cancer research. He is a guest editor for Current Opinion in Obstetrics and Gynecology and serves as an editorial reviewer for 10 medical journals. Dr. Farias-Eisner is also a prolific contributor to peer-reviewed medical journals and medical textbooks on the subject of gynecologic oncology and biomarker science as it applies to the detection of gynecologic cancer.
Dr. Friedman is one of the world's leading experts in the area of pathology and laboratory informatics, which is the medical discipline that addresses the storage, retrieval, and publication of information generated in pathology and the hospital clinical laboratories. He is board-certified in both anatomic and clinical pathology and served as a faculty member in the Department of Pathology, University of Michigan Medical School, for 33 years. His affiliation with the Department continues after his retirement as an Active Emeritus Professor. While active in the department, he served as the co-director of Division of Pathology Informatics in the Department and also as the Director of Clinical Support Services, Medical Center Information Technology, for the University of Michigan Health System. He was the founding co-president of the Association for Pathology Informatics. He has served as the director of a yearly conference on pathology informatics for 25 years. For the past for years, this conference, Lab InfoTech Summit, has been presented in Las Vegas under the sponsorship of the Pathology Education Consortium of which he is president. He is the author of a well-known clinical laboratory blog, Lab Soft News. He is also the author of some 90 scientific articles, book chapters and abstracts.
Dr. Hunder is one of the world's leading experts in the area of rheumatology. He is board certified in Internal Medicine and Rheumatology and served as a faculty member in the Department of Rheumatology, Mayo Graduate School of Medicine for 33 years. His affiliation with the Department continues after his retirement as an Active Emeritus Professor. While active in the department, he served as the Chair of the Rheumatology Research Committee and Chair of Division of Rheumatology. He was also a member of the Board of Trustees of the National Arthritis Foundation, member of the Board of Directors of the American College of Rheumatology and President of the American Society of Clinical Rheumatology. He is also the author of some 417 scientific articles publications.
Dr. Kopecky is a respected cardiologist, who specializes in preventing heart disease. A graduate of the University of Texas Health Science Center at Houston, he completed his clinical internship and residency in internal medicine and a fellowship in cardiovascular diseases at the Mayo Graduate School of Medicine in Rochester, Minnesota. After performing intervention procedures to treat heart attacks at the Mayo Clinic for 18 years, Dr. Kopecky turned his attention to finding ways to prevent heart disease. He currently works in the Cardiovascular Health Clinic, the prevention clinic in the Division of Cardiovascular Diseases at the Mayo Clinic, where he is researching the role of inflammation in cardiovascular disease and how lifestyle — including a Mediterranean diet, exercise and proper nutrition — influence the progression of cardiovascular disease. He has authored numerous articles on his research findings, which have been published in peer-reviewed medical journals such as American Heart Journal, American Journal of Cardiology, American Journal of Medicine, Circulation, JAMA and New England Journal of Medicine. Dr. Kopecky is also the recipient of multiple Teacher of the Year awards from the division of Cardiovascular Diseases and the Department of Internal Medicine at the Mayo Medical School.
Our Management Team
Biophysical leadership profiles
Randy Marfin joined Biophysical Corp in October 2008 as CEO. Prior to joining us, he worked for ten years at Luminex Corporation, most recently as Vice President of Strategic Development, where he was responsible for corporate strategic planning. In addition, Randy served as Vice President of Sales and Marketing for SpectraCell Laboratories, Inc, a blood-based wellness clinical laboratory, where he was responsible for business development, acquisitions, strategic planning and sales and marketing. From 1986 to 1995, he held general management, business development and sales management positions for MPC Laboratories, Damon Clinical Laboratories, Nichols Institute and Quest Diagnostics (formerly Corning).
Dr. Rodgers graduated summa cum laude from Harvard University and the University of Texas Southwestern Medical School in Dallas. He completed his residency training at the University of Texas Medical School and cardiology fellowship at the Baylor College of Medicine in Houston. Dr. Rodgers is board-certified in both Internal Medicine and the sub-specialty of Cardiovascular Disease and entered private practice in Austin, Texas, in 1989. Prior to joining Biophysical as president and chief medical officer, he was medical director for Heart Hospital of Austin, one of the nation’s premier facilities for cardiovascular care. He was also president of the Austin Heart cardiology group from 1999 to 2004, where he continues to practice clinical cardiology. A noted authority in providing cardiovascular care and information to residents of Central Texas, he has served on numerous regional and national committees on cardiovascular disease throughout his career. He was elected chairman for the American College of Cardiology Board of Governors in 2007 and also serves as president of the Austin Heart Foundation and president of the Texas Chapter of the American College of Cardiology. The principal investigator for numerous research projects, Dr. Rodgers has published more than 40 clinical articles in medical journals and is a member of the American Heart Hospital Journal editorial board. He has a special interest in the early detection and treatment of atherosclerosis and is the founding member of the Society of Atherosclerosis Imaging.
Trent joined Biophysical Corporation in March 2012 as CFO. Prior to joining Biophysical,Trent was a Founding Partner of Grand Slam Finance, Inc., providing full financial operations services to political organizations. Before starting Grand Slam Finance, Trent served as COO and CFO for TechTurn, Ltd., where he was responsible for operations at the company¹s facilities in Austin, TX and Ashland, VA, as well as accounting, finance, reporting, information technology, human resources, and risk management. Trent¹s career also includes an eight year tenure in the finance organization at Dell, Inc., positions in Corporate Finance at Associates First Capital Corporation, the Controllership of a Medicare home health agency, and in the audit department of Price Waterhouse.
Our Board of Directors
A board of internationally renowned physicians, scientists and executives
Mark Chandler received his Ph.D. in Immunology from the University of Texas Southwestern Medical School in Dallas in 1981. In 1982, he founded Inland Laboratories, Inc., which provides plant and bacterial toxins to the medical research community. As the President and CEO of Inland Laboratories, Chandler received the KPMG LLP, High Technology Entrepreneur of the Year Award in 1987. He cofounded Luminex Corporation (NASDAQ: LMNX) in 1995 and served as Chairman of the Board and CEO until Rules-Based Medicine was spun out of Luminex in 2002 at which time he assumed the role as CEO and Chairman of RBM. He recently stepped back from his positions with RBM to focus his time and energies exclusively on the Biophysical business opportunities.
Craig Benson joined Rules-Based Medicine, Inc. in January 2002 to direct its spin-off from Luminex Corporation. Until 2004, Benson also served as Chairman of the Board for Equity Resource Partners, LLC, a private investment company. From 1987 through September 2000, he was employed by Service Corporation International (NYSE: SCI), a world leader in death care-related services. During his tenure with SCI, he held various senior executive management positions, which included domestic and international merger and acquisition responsibilities, vice-president of Marketing and Corporate Alliances, as well as president of SCI International, Ltd., SCI's International holding company. From 1990 to 1994, Benson served as president of Investment Capital Corporation, the private equity arm of SCI, which held over $350 million in assets. From 1984 to 1987, he held management positions with Pulaski Investment Corporation, a private holding company engaged in commercial and mortgage banking activities. Benson has served on the Board of Directors of various publicly held entities, including Florafax International, Tanknology Environmental, Inc., Equity Corporation International and Pinnacle Global Group, Inc. He received a BBA degree from Southern Methodist University in 1984.
Mr. Ragard is a principal of Friess Associates, manager of the Brandywine Funds and an affiliate of New York Stock Exchange-listed Affiliated Managers Group. He is responsible for a team that manages approximately $2 billion of client assets invested in public growth stocks and is focused on the health care and energy industries. During the five years ended 12/31/05, assets for which he was responsible appreciated by over $1 billion, compounding at 28% per annum while, during the same time, the Standard & Poor's 500 rose by only 0.5% percent per year. Previously Mr. Ragard was a managing partner of venture capital firm Horsley Bridge, a leading investor in U.S.-based private companies. Successful private health care investments made by Horsley Bridge include Genentech, Hybritech and IDEC Pharmaceuticals. Mr. Ragard graduated cum laude from the University of Pennsylvania's Wharton School of Business and is a chartered financial analyst.
Mr. Charbonnet earned his Bachelor of Science degree from the University of Virginia. After graduating from UVA in 1990, Mr. Charbonnet worked in the Corporate Finance Department at the Robinson-Humphrey Company in Atlanta until 1995. Mr. Charbonnet is a Partner at Johnson Rice & Company, LLC, where he has been employed since March of 1995. He is co-founder of Green Turtle Partners, LP, and the managing member of Green Turtle Capital Management, LLC. Mr. Charbonnet serves on the Board of Directors of Good Shepherd Nativity Mission School, an inner-city school.
Dr. Lyons received his MD degree from the University of Texas Southwestern Medical School in 1987 and completed residency training in Internal Medicine at Brigham and Women's Hospital. He earned a fellowship in Oncology/Hematology at Brigham and Women's Hospital and is board-certified in Internal Medicine and Hematology. Dr. Lyons is an assistant professor at the University of New Mexico Department of Internal Medicine and his special interests and expertise are hematology/oncology and mycobacterium tuberculosis.
A veteran of scores of award-winning marketing campaigns, Mr. Temerlin maintains a private consulting practice in Dallas. He began his advertising career as a copywriter with Glenn Advertising in 1953, later serving in a number of capacities before being named chairman in 1970. Under his leadership, the agency began acquiring the national and international accounts that propelled Dallas into a position as one of the premier centers for advertising in the nation. During his more than 50 years of association with the agency and its successors, Mr. Temerlin established long-time client relationships with major corporations such as Bank of America, Hyatt Hotels, Subaru, American Airlines, JCPenney, Pfizer, Warner Lambert, ExxonMobil and Texas Instruments. In 2001 the school of advertising at Southern Methodist University was named in Mr. Temerlin's honor, and he was inducted into the American Advertising Federation's Hall of Fame in 2004. In addition to these and many other honors, Mr. Temerlin has held leadership positions with a number of national, academic and civic-based organizations including the American Film Institute, Southern Methodist University, Southwestern Medical Foundation, the Dallas Museum of Art and the Dallas Symphony Association.